Short answer · Medically reviewed summary · Last updated: 2026-05-08
Treatment for Osteonecrosis, also known as avascular necrosis, is highly personalized and depends on the stage of bone death, the size of the lesion, and the affected joint. Current medical guidelines emphasize a combination of conservative management to reduce symptoms and surgical interventions to preserve the joint or replace it when structural collapse occurs. What are the first-line treatments for Osteonecrosis? In the early stages of Osteonecrosis, clinicians often focus on slowing disease progression through conservative measures.
14 people with Osteonecrosis have shared their first-person experience on this question at DiseaseMaps.
Treatment for Osteonecrosis, also known as avascular necrosis, is highly personalized and depends on the stage of bone death, the size of the lesion, and the affected joint. Current medical guidelines emphasize a combination of conservative management to reduce symptoms and surgical interventions to preserve the joint or replace it when structural collapse occurs.
In the early stages of Osteonecrosis, clinicians often focus on slowing disease progression through conservative measures. This includes protected weight-bearing (using crutches or walkers to offload the joint), physical therapy to maintain range of motion, and pain management. While medication cannot reverse Osteonecrosis, it is used to manage symptoms and improve quality of life.
Management of Osteonecrosis often involves a multidisciplinary approach. Common interventions include:
Because Osteonecrosis is a complex condition, a coordinated care team is essential. Patients typically benefit from a team including an orthopedic surgeon, a rheumatologist (to manage underlying inflammatory conditions), a physical therapist, and a pain management specialist. At DiseaseMaps.org, 410 people with Osteonecrosis have shared their experiences, highlighting the value of connecting with others to navigate these clinical pathways.
Research into regenerative medicine is ongoing, with clinical trials exploring the use of stem cell therapy and platelet-rich plasma (PRP) to stimulate bone regeneration in early-stage Osteonecrosis. While these therapies show promise in small studies, they are not yet considered standard of care and should be discussed with a specialist.
Medical disclaimer: This information is for educational purposes only and does not replace professional medical advice, diagnosis, or treatment; always consult your personal healthcare team for decisions regarding your health.